| 1 |
25688159 | Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial. | 2015 May 15 |
2 |
| 2 |
23394575 | Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway. | 2013 Feb 9 |
2 |
| 3 |
21971587 | A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells. | 2012 Apr |
3 |